USD 0.01
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -67 Thousand USD | 21.18% |
2022 | -85 Thousand USD | 61.36% |
2021 | -220 Thousand USD | -3.29% |
2020 | -213 Thousand USD | 72.23% |
2019 | -767 Thousand USD | 0.0% |
2013 | 981 Thousand USD | 605.76% |
2012 | 139 Thousand USD | 109.35% |
2011 | -1.48 Million USD | 72.96% |
2010 | -5.49 Million USD | 41.52% |
2009 | -9.39 Million USD | -706.32% |
2008 | 1.55 Million USD | 228.39% |
2007 | 472 Thousand USD | -68.82% |
2006 | 1.51 Million USD | -75.33% |
2005 | 6.13 Million USD | -10.3% |
2004 | 6.84 Million USD | -15.74% |
2003 | 8.12 Million USD | 208.01% |
2002 | -7.51 Million USD | -181.1% |
2001 | 9.27 Million USD | 567.95% |
2000 | -1.98 Million USD | -168.31% |
1999 | 2.9 Million USD | 115.51% |
1998 | -18.7 Million USD | -345.24% |
1997 | -4.2 Million USD | -143.3% |
1996 | 9.7 Million USD | -28.68% |
1995 | 13.6 Million USD | 29.52% |
1994 | 10.5 Million USD | 54.41% |
1993 | 6.8 Million USD | 19.3% |
1992 | 5.7 Million USD | -5.0% |
1991 | 6 Million USD | 87.5% |
1990 | 3.2 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -14 Thousand USD | 0.0% |
2023 Q2 | -30 Thousand USD | 9.09% |
2023 Q1 | -33 Thousand USD | 0.0% |
2023 Q3 | - USD | 100.0% |
2023 FY | -67 Thousand USD | 21.18% |
2022 FY | -85 Thousand USD | 61.36% |
2022 Q2 | -40 Thousand USD | -73.91% |
2022 Q1 | -23 Thousand USD | 0.0% |
2021 Q1 | -90 Thousand USD | 0.0% |
2021 FY | -220 Thousand USD | -3.29% |
2021 Q2 | -91 Thousand USD | -1.11% |
2020 FY | -213 Thousand USD | 72.23% |
2019 FY | -767 Thousand USD | 0.0% |
2018 Q2 | 399 Thousand USD | 472.9% |
2018 Q1 | -107 Thousand USD | 0.0% |
2018 Q3 | 1.06 Million USD | 166.67% |
2018 Q4 | 56 Thousand USD | -94.74% |
2017 Q3 | 209.00 USD | 0.0% |
2016 Q3 | 70.00 USD | 0.0% |
2014 Q2 | 41 Thousand USD | 112.62% |
2014 Q1 | -325 Thousand USD | 0.0% |
2014 Q3 | -138 Thousand USD | -436.59% |
2013 Q3 | -234 Thousand USD | -179.05% |
2013 Q2 | 296 Thousand USD | -26.37% |
2013 Q1 | 402 Thousand USD | 282.86% |
2013 FY | 981 Thousand USD | 605.76% |
2012 Q2 | 531 Thousand USD | 375.13% |
2012 Q4 | 105 Thousand USD | -31.37% |
2012 FY | 139 Thousand USD | 109.35% |
2012 Q1 | -193 Thousand USD | -14.88% |
2012 Q3 | 153 Thousand USD | -71.19% |
2011 Q1 | 126 Thousand USD | 120.39% |
2011 FY | -1.48 Million USD | 72.96% |
2011 Q4 | -168 Thousand USD | -409.09% |
2011 Q3 | -33 Thousand USD | -145.83% |
2011 Q2 | 72 Thousand USD | -42.86% |
2010 FY | -5.49 Million USD | 41.52% |
2010 Q3 | -1.15 Million USD | 10.85% |
2010 Q2 | -1.3 Million USD | 9.09% |
2010 Q1 | -1.43 Million USD | -22.96% |
2010 Q4 | -618 Thousand USD | 46.68% |
2009 Q2 | -4.65 Million USD | -47.06% |
2009 Q4 | -1.16 Million USD | 27.45% |
2009 Q3 | -1.6 Million USD | 65.57% |
2009 Q1 | -3.16 Million USD | -157.61% |
2009 FY | -9.39 Million USD | -706.32% |
2008 Q3 | 270 Thousand USD | 381.25% |
2008 Q2 | -96 Thousand USD | -108.03% |
2008 Q1 | 1.19 Million USD | 235.01% |
2008 FY | 1.55 Million USD | 228.39% |
2008 Q4 | -1.22 Million USD | -555.19% |
2007 Q3 | 93 Thousand USD | 173.23% |
2007 Q2 | -127 Thousand USD | -323.33% |
2007 Q4 | 357 Thousand USD | 283.87% |
2007 FY | 472 Thousand USD | -68.82% |
2007 Q1 | -30 Thousand USD | -112.2% |
2006 Q3 | 383 Thousand USD | 403.95% |
2006 FY | 1.51 Million USD | -75.33% |
2006 Q1 | 487 Thousand USD | -1.42% |
2006 Q2 | 76 Thousand USD | -84.39% |
2006 Q4 | 246 Thousand USD | -35.77% |
2005 FY | 6.13 Million USD | -10.3% |
2005 Q1 | 1.82 Million USD | -5.28% |
2005 Q2 | 776 Thousand USD | -57.55% |
2005 Q4 | 494 Thousand USD | 8.1% |
2005 Q3 | 457 Thousand USD | -41.11% |
2004 FY | 6.84 Million USD | -15.74% |
2004 Q4 | 1.93 Million USD | 21.0% |
2004 Q3 | 1.59 Million USD | -29.86% |
2004 Q2 | 2.27 Million USD | 26.69% |
2004 Q1 | 1.79 Million USD | 60.27% |
2003 Q4 | 1.12 Million USD | -18.9% |
2003 Q2 | 692 Thousand USD | -16.22% |
2003 Q1 | 826 Thousand USD | -76.03% |
2003 FY | 8.12 Million USD | 208.01% |
2003 Q3 | 1.38 Million USD | 99.57% |
2002 Q1 | 173 Thousand USD | -88.25% |
2002 Q2 | -11.17 Million USD | -6560.12% |
2002 Q3 | 2.88 Million USD | 125.81% |
2002 Q4 | 3.44 Million USD | 19.49% |
2002 FY | -7.51 Million USD | -181.1% |
2001 Q1 | -6.37 Million USD | -546.33% |
2001 Q3 | 2.62 Million USD | -78.17% |
2001 Q4 | 1.47 Million USD | -43.95% |
2001 FY | 9.27 Million USD | 567.95% |
2001 Q2 | 12.02 Million USD | 288.57% |
2000 Q1 | 4.67 Million USD | 768.14% |
2000 Q4 | 1.42 Million USD | -19.36% |
2000 FY | -1.98 Million USD | -168.31% |
2000 Q2 | -6.16 Million USD | -231.9% |
2000 Q3 | 1.77 Million USD | 128.72% |
1999 Q3 | 100 Thousand USD | -96.55% |
1999 FY | 2.9 Million USD | 115.51% |
1999 Q4 | -700 Thousand USD | -800.0% |
1999 Q1 | -100 Thousand USD | 50.0% |
1999 Q2 | 2.9 Million USD | 3000.0% |
1998 Q2 | 1.4 Million USD | 116.67% |
1998 Q3 | 200 Thousand USD | -85.71% |
1998 Q4 | -200 Thousand USD | -200.0% |
1998 FY | -18.7 Million USD | -345.24% |
1998 Q1 | -8.4 Million USD | 13.4% |
1997 Q2 | -7.7 Million USD | -527.78% |
1997 FY | -4.2 Million USD | -143.3% |
1997 Q3 | -2.2 Million USD | 71.43% |
1997 Q1 | 1.8 Million USD | 125.0% |
1997 Q4 | -9.7 Million USD | -340.91% |
1996 FY | 9.7 Million USD | -28.68% |
1996 Q4 | 800 Thousand USD | 0.0% |
1996 Q3 | 800 Thousand USD | -84.62% |
1996 Q2 | 5.2 Million USD | 5100.0% |
1996 Q1 | 100 Thousand USD | -95.65% |
1995 Q2 | -600 Thousand USD | -112.5% |
1995 FY | 13.6 Million USD | 29.52% |
1995 Q4 | 2.3 Million USD | -20.69% |
1995 Q3 | 2.9 Million USD | 583.33% |
1995 Q1 | 4.8 Million USD | 4.35% |
1994 Q2 | 3.7 Million USD | 68.18% |
1994 Q1 | 2.2 Million USD | 4.76% |
1994 FY | 10.5 Million USD | 54.41% |
1994 Q4 | 4.6 Million USD | -2.13% |
1994 Q3 | 4.7 Million USD | 27.03% |
1993 Q1 | 1 Million USD | -28.57% |
1993 FY | 6.8 Million USD | 19.3% |
1993 Q4 | 2.1 Million USD | -22.22% |
1993 Q3 | 2.7 Million USD | 3.85% |
1993 Q2 | 2.6 Million USD | 160.0% |
1992 Q1 | 1.9 Million USD | 35.71% |
1992 Q2 | 900 Thousand USD | -52.63% |
1992 Q3 | 1.8 Million USD | 100.0% |
1992 FY | 5.7 Million USD | -5.0% |
1992 Q4 | 1.4 Million USD | -22.22% |
1991 Q3 | 1.6 Million USD | -11.11% |
1991 Q1 | 1.5 Million USD | -83.15% |
1991 Q2 | 1.8 Million USD | 20.0% |
1991 FY | 6 Million USD | 87.5% |
1991 Q4 | 1.4 Million USD | -12.5% |
1990 FY | 3.2 Million USD | 0.0% |
1990 Q2 | -15.4 Million USD | -348.39% |
1990 Q4 | 8.9 Million USD | 1.14% |
1990 Q1 | 6.2 Million USD | 0.0% |
1990 Q3 | 8.8 Million USD | 157.14% |
1989 Q3 | 6.2 Million USD | 0.0% |
1989 Q4 | 6.2 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
CVR Medical Corp. | - USD | Infinity% |
BioElectronics Corporation | -274.29 Thousand USD | 75.573% |
IR-Med Inc. | -4.91 Million USD | 98.636% |
Polarean Imaging plc | -12.55 Million USD | 99.466% |
Medical Supply International USA, Inc. | 438.18 Thousand USD | 115.291% |
Avitar, Inc. | 2.73 Million USD | 102.452% |
AVITA Medical, Inc. | -40.4 Million USD | 99.834% |
Manhattan Scientifics, Inc. | -703 Thousand USD | 90.469% |
Össur hf. | 87.46 Million USD | 100.077% |
Zecotek Photonics Inc. | -3.65 Million USD | 98.168% |
QHSLab, Inc. | -240.15 Thousand USD | 72.102% |
Wellstar International, Inc. | -1.79 Million USD | 96.267% |
Össur hf. | 87.46 Million USD | 100.077% |
Bionovate Technologies Corp | - USD | Infinity% |
EKF Diagnostics Holdings plc | 2.08 Million USD | 103.22% |
Escalon Medical Corp. | -104.47 Thousand USD | 35.87% |
Aurora Spine Corporation | -446.19 Thousand USD | 84.984% |
BrainsWay Ltd. | -4.92 Million USD | 98.64% |
Lattice Biologics Ltd. | - USD | Infinity% |
NewCardio, Inc. | -9.45 Million USD | 99.292% |
Hamilton Thorne Ltd. | 277.99 Thousand USD | 124.101% |
Vivos Inc. | -2.79 Million USD | 97.601% |
MicroPort Scientific Corporation | -516.16 Million USD | 99.987% |
Kelyniam Global, Inc. | -239.16 Thousand USD | 71.986% |
REMSleep Holdings, Inc. | -1.77 Million USD | 96.218% |
CYduct Diagnostics, Inc. | -378.9 Thousand USD | 82.318% |
Nanomix Corporation | -8.43 Million USD | 99.206% |
Theraclion SA | -3.48 Million USD | 98.075% |
Lifeline Biotechnologies, Inc. | - USD | Infinity% |
Wellness Center USA, Inc. | -707.02 Thousand USD | 90.524% |
Positron Corporation | -1.36 Million USD | 95.076% |
Rafina Innovations Inc. | - USD | Infinity% |
Electromedical Technologies, Inc. | -2.06 Million USD | 96.755% |
Lombard Medical, Inc. | -29.33 Million USD | 99.772% |
ALR Technologies Inc. | -2.94 Million USD | 97.726% |
Stratec SE | 25.26 Million USD | 100.265% |
Vycor Medical, Inc. | 40.19 Thousand USD | 266.704% |
Heart Tronics, Inc. | 14.46 Million USD | 100.463% |
Nu-Med Plus, Inc. | -120.52 Thousand USD | 44.41% |
Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 99.677% |
SANUWAVE Health, Inc. | -540 Thousand USD | 87.593% |
VMS Rehab Systems, Inc. | -68.66 USD | -97482.29% |
Guided Therapeutics, Inc. | -3.45 Million USD | 98.062% |
Ingen Technologies, Inc. | -1.61 Million USD | 95.848% |
Odyssey Group International, Inc. | 14.26 Million USD | 100.47% |
ECGI Holdings, Inc. | -407.48 Thousand USD | 83.557% |
Capital Group Holdings, Inc. | -634.68 Thousand USD | 89.444% |
ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 88.862% |
Urologix, Inc. | -6.93 Million USD | 99.033% |
Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 94.697% |
Nexeon MedSystems Inc. | -6.26 Million USD | 98.931% |
SS Innovations International, Inc. | -20.66 Million USD | 99.676% |
Qualis Innovations, Inc. | -230.24 Thousand USD | 70.9% |
Smith & Nephew plc | 425 Million USD | 100.016% |
NIOX Group Plc | 4.6 Million USD | 101.457% |
Fuse Medical, Inc. | 383.82 Thousand USD | 117.456% |
Broncus Holding Corporation | -33.22 Million USD | 99.798% |
Brain Scientific Inc. | -9.6 Million USD | 99.303% |
Pressure BioSciences, Inc. | -9.5 Million USD | 99.295% |
Health Logic Interactive Inc. | -60.69 Thousand USD | -10.381% |